NCT06588777

Brief Summary

This study aims to compare the efficacy of using Ultrasound guided modified thoracoabdominal nerve block through perichondrial approach (M-TAPA) versus quadratus lumborum block for postoperative analgesia in laparoscopic cholecystectomy under general anesthesia.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
52

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 1, 2024

Completed
Same day until next milestone

Study Start

First participant enrolled

September 1, 2024

Completed
18 days until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2025

Completed
Last Updated

September 30, 2025

Status Verified

September 1, 2025

Enrollment Period

1.3 years

First QC Date

September 1, 2024

Last Update Submit

September 29, 2025

Conditions

Keywords

Laparoscopic cholecystectomymodified thoracoabdominal nerve blockquadratus lumborum block

Outcome Measures

Primary Outcomes (1)

  • Time to first Rescue Analgesia

    Is to measure the first time to resque analgesia postoperative (24 hours)

    24 hours postoperative

Secondary Outcomes (4)

  • The total requirements of rescue analgesia Meperidine (pethidine) over the first 24 hours postoperative

    24 hours postoperative

  • Heart rate

    at intervals of 0 (PACU), 1, 2, 4, 6, 12, 18 and 24 hours postoperatively

  • Blood pressure

    at intervals of 0 (PACU), 1, 2, 4, 6, 12, 18 and 24 hours postoperatively

  • Spo2 measuring

    at intervals of 0 (PACU), 1, 2, 4, 6, 12, 18 and 24 hours postoperatively

Study Arms (2)

Modified thoracoabdominal nerve block through perichondrial approach (M-TAPA)

EXPERIMENTAL

Using the in plane technique A deep angle was given to the costochondral angle at the edge of the 10th costal margin with the probe in the sagittal direction to view the lower surface of the costal cartilage in the midline. A 22-G, 100-mm block needle will be inserted in the cranial direction using the in-plane technique and the needle tip will be moved to the posterior aspect of the 10th costal cartilage. It is noted that the needle tip never crossed the cranial edge of the 10th costal cartilage and 20 mL of 0.25% bupivacaine will be injected into the lower surface of the chondrium to make Modified thoracoabdominal nerve block through perichondrial approach (M-TAPA).

Procedure: Modified thoracoabdominal nerve block through perichondrial approach (M-TAPA)

Quadratus lumborum block

EXPERIMENTAL

Using the in plane technique the probe will be placed in the mid-axillary line between the lower costal margin and the iliac crest in a transverse plane to view all abdominal layers. The probe will be moved towards the posterior axillary line, to reach a point where all three abdominal muscle layers merge to form aponeurosis. The aponeurosis will then be followed dorsally until the quadratus lumborum muscle is seen deep to transversalis fascia with its attachment to the transverse process of the L4 vertebral body. A 22 G, 100 mm, blunt, insulated nerve block needle will be inserted 1 cm medial to the probe and advanced using the in-plane technique with ultrasound real-time assessment. The injection site will be the junction of transversalis fascia and the anterolateral border of quadratus lumborum muscle.

Procedure: Quadratus lumborum block

Interventions

transversus abdominis, internal oblique, and external oblique muscles will be identified with a high-frequency (10 MHz) linear probe on the costochondral angle in the sagittal plane under ultrasound guidance at the 10th costal margin. A deep angle was given to the costochondral angle at the edge of the 10th costal margin with the probe in the sagittal direction to view the lower surface of the costal cartilage in the midline. A 22-G, 100-mm block needle will be inserted in the cranial direction using the in-plane technique and the needle tip will be moved to the posterior aspect of the 10th costal cartilage. It is noted that the needle tip never crossed the cranial edge of the 10th costal cartilage

Also known as: (M-TAPA)
Modified thoracoabdominal nerve block through perichondrial approach (M-TAPA)

using ultrasound guidance (Sonosite turbo M, Bothell, Washington, USA) and a curved ultrasound probe (2.5-7.5 MHz). The probe will be placed in the mid-axillary line between the lower costal margin and the iliac crest in a transverse plane to view all abdominal layers. The probe will be moved towards the posterior axillary line, to reach a point where all three abdominal muscle layers merge to form aponeurosis. The aponeurosis will then be followed dorsally until the quadratus lumborum muscle is seen deep to transversalis fascia with its attachment to the transverse process of the L4 vertebral body. A 22 G, 100 mm, blunt, insulated nerve block needle will be inserted 1 cm medial to the probe and advanced using the in-plane technique with ultrasound real-time assessment. The injection site will be the junction of transversalis fascia and the anterolateral border of quadratus lumborum muscle

Also known as: (QLB)
Quadratus lumborum block

Eligibility Criteria

Age21 Years - 71 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients aging ≥ 21 years to ≤ 70 of both sexes.
  • Patients undergoing Laparoscopic cholecystectomy surgeries.
  • ASA physical status classes I - II.

You may not qualify if:

  • Patient's refusal of procedure or participation in the study.
  • ASA classes III or above.
  • Coagulopathy and bleeding disorders.
  • Evidence of Local skin infections at site of injection.
  • Body mass index \>40kg/m2
  • A history of relevant local anesthetic allergy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ainshams university hospitals

Cairo, Egypt

RECRUITING

Central Study Contacts

Ahmed Hassan, Master

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Doctor

Study Record Dates

First Submitted

September 1, 2024

First Posted

September 19, 2024

Study Start

September 1, 2024

Primary Completion

December 30, 2025

Study Completion

December 30, 2025

Last Updated

September 30, 2025

Record last verified: 2025-09

Locations